×
About 22,525 results

ALLMedicine™ Vasculitis Center

Research & Reviews  7,500 results

Secukinumab-induced IgA vasculitis in a patient with psoriatic arthritis.
https://doi.org/10.1111/1756-185X.14667
International Journal of Rheumatic Diseases; Ozince RB, Ak T et. al.

Mar 18th, 2023 - Secukinumab (SEC) is an effective and widely used drug in psoriatic disease and axial spondyloarthritis. However, SEC has been found to be associated with inflammatory conditions and vasculitis. These inflammatory adverse effects may complicate th...

EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.
https://doi.org/10.1136/ard-2022-223764
Annals of the Rheumatic Diseases; Hellmich B, Sanchez-Alamo B et. al.

Mar 18th, 2023 - Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several randomised clinical trials have been published that have the potential to change clini...

Reactive arthritis following COVID-19 current evidence, diagnosis, and management strat...
https://doi.org/10.1186/s13018-023-03651-6
Journal of Orthopaedic Surgery and Research; Migliorini F, Bell A et. al.

Mar 17th, 2023 - Immune-mediated conditions associated to Corona Virus Disease-19 (COVID-19) have been reported, including vasculitis, antiphospholipid antibody syndrome, myositis, and lupus. Emerging studies have reported the potential occurrence of reactive arth...

Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclero...
https://doi.org/10.1016/j.autrev.2023.103312
Autoimmunity Reviews; Konen FF, Möhn N et. al.

Mar 17th, 2023 - More than 10 disease-modifying therapies (DMT) are approved by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) for the treatment of multiple sclerosis (MS) and new therapeutic options are on the horizon. Due to di...

Malignant syphilis as the presenting complaint of advanced HIV.
https://doi.org/10.1177/09564624231162415
International Journal of STD & AIDS; Montenegro-Idrogo JJ, Muñante R et. al.

Mar 16th, 2023 - Malignant syphilis is an infrequent secondary manifestation in patients with human immunodeficiency virus (HIV), with polymorphous and disseminated skin lesions being related to severe immunosuppression. Lesions have intense inflammatory circinate...

see more →

Guidelines  22 results

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease
https://www.rheumatology.org/Portals/0/Files/Guideline-Management-Kawasaki-Disease.pdf
American College of Rheumatology; Gorelik M, .

Mar 8th, 2022 - Kawasaki disease (KD) is a medium vessel vasculitis as presented in the Chapel Hill Consensus Conference nomenclature system (1). It is 1 of 2 primary common vasculitis syndromes that predominantly affect children (the other being IgA vasculitis...

Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis:...
https://doi.org/10.1136/bmj-2021-064597
BMJ (Clinical Research Ed.); Zeng L, Walsh M et. al.

Feb 27th, 2022 - What is the role of plasma exchange and what is the optimal dose of glucocorticoids in the first 6 months of therapy of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)? This guideline was triggered by the publi...

2022 American College of Rheumatology/European Alliance of Associations for Rheumatolog...
https://doi.org/10.1002/art.41983
Arthritis & Rheumatology (Hoboken, N.J.); Suppiah R, Robson JC et. al.

Feb 3rd, 2022 - To develop and validate classification criteria for microscopic polyangiitis (MPA). Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) identification of candidate items ...

2022 American College of Rheumatology/European Alliance of Associations for Rheumatolog...
https://doi.org/10.1002/art.41986
Arthritis & Rheumatology (Hoboken, N.J.); Robson JC, Grayson PC et. al.

Feb 3rd, 2022 - To develop and validate revised classification criteria for granulomatosis with polyangiitis (GPA). Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) identification of ...

2022 American College of Rheumatology/European Alliance of Associations for Rheumatolog...
https://doi.org/10.1002/art.41982
Arthritis & Rheumatology (Hoboken, N.J.); Grayson PC, Ponte C et. al.

Feb 3rd, 2022 - To develop and validate revised classification criteria for eosinophilic granulomatosis with polyangiitis (EGPA). Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 5 phases: 1) iden...

see more →

Drugs  299 results see all →

Clinicaltrials.gov  340 results

RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
https://clinicaltrials.gov/ct2/show/NCT05758831

Mar 7th, 2023 - Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS). This disease is the leading cause of non-traumatic disability in young adults and France is characterized by a high prevalence (currently 1/1000 inh...

FDG-PET Imaging in Complicated Diabetic Foot
https://clinicaltrials.gov/ct2/show/NCT00194298

Mar 6th, 2023 - FDG-PET imaging is a promising imaging technique, which has the potential to overcome many of the shortcomings mentioned previously with regard to radiologic and scintigraphic methodologies. FDG is a diagnostic tracer utilized to measure the metab...

Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission
https://clinicaltrials.gov/ct2/show/NCT05380453

Mar 3rd, 2023 - Recent scientific evidence identified an association between polymorphisms within the IL-17A locus and GCA, supporting a role for IL-17A in vasculitis pathophysiology. Analysis of the inflammatory processes in the aortic wall has indicated that in...

Statins Study in Kawasaki Disease Children With Coronary Artery Abnormalities
https://clinicaltrials.gov/ct2/show/NCT03915795

Mar 2nd, 2023 - Kawasaki disease (KD) is an acute self-limited vasculitis and occurs almost exclusively in childhood. It predominantly affects medium-sized arteries, most commonly the coronary arteries. Although the use of intravenous immunoglobulin (IVIG) has ob...

COVID-19 Infection in Patients Receiving Anti-CD20 Therapy
https://clinicaltrials.gov/ct2/show/NCT04884477

Mar 1st, 2023 - This is a retrospective cohort study comparing patients, with newly diagnosed COVID-19 infection, previously treated with anti-CD20 drugs for diseases including vasculitis or hematologic malignancy, who are given high titer convalescent plasma wit...

see more →

News  797 results

JAK Inhibitor Succeeds in Refractory Vasculitis
https://www.medpagetoday.com/rheumatology/generalrheumatology/103556

Mar 16th, 2023 - Patients with treatment-resistant granulomatosis with polyangiitis (GPA) may see improvement with tofacitinib (Xeljanz), results of a small trial suggested. Among 11 patients for whom at least four previous drugs had failed, seven showed strong re...

Experts share early details prescribing avacopan for ANCA-associated vasculitis
https://www.mdedge.com/rheumatology/article/261785/lupus-connective-tissue-diseases/experts-share-early-details-prescribing
Jeff Craven

Mar 14th, 2023 - When the Food and Drug Administration approved avacopan (Tavneos) as an adjunctive treatment for severe, active antineutrophil cytoplasmic autoantibody (ANCA)–associated vasculitis (AAV) in October 2021, the oral complement C5a receptor inhibitor.

ANCA-Associated Vasculitis: Parsing the Kidney Complications
https://www.medpagetoday.com/rheumatology/generalrheumatology/103384

Mar 3rd, 2023 - Bearing in mind that renal impairment is among the worst complications of ANCA-associated vasculitis (AAV), researchers have identified four different trajectories of kidney function over time in AAV patients, with implications for personalized tr...

Hemorrhagic Lacrimation and Epistaxis: Rare Findings in Acute Hemorrhagic Edema of Infancy
https://www.mdedge.com/dermatology/article/260967/pediatrics/hemorrhagic-lacrimation-and-epistaxis-rare-findings-acute
Pavela G. Bambekova, MD, Jose A. Cervantes, MD et. al.

Feb 1st, 2023 - To the Editor: Hemorrhagic lacrimation and epistaxis are dramatic presentations with a narrow differential diagnosis. It rarely has been reported to present alongside the more typical features of acute hemorrhagic edema of infancy (AHEI), which is.

Palmar rash
https://www.mdedge.com/familymedicine/article/260933/dermatology/palmar-rash
MDedge Family Medicine;

Jan 31st, 2023 - This patient’s targetoid and tingling skin lesions, in association with herpes simplex virus (HSV) infection, are a classic presentation of erythema multiforme (EM). EM is an acute, self-limited, immune-mediated process that most commonly arises i.

see more →

Patient Education  52 results see all →